Format

Send to

Choose Destination
Nat Rev Immunol. 2009 Mar;9(3):213-20. doi: 10.1038/nri2494.

Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines.

Author information

1
Department of Paediatrics, University of Oxford, Level 2, Children's Hospital, Oxford, UK. andrew.pollard@paediatrics.ox.ac.uk

Abstract

Polysaccharide-encapsulated organisms are the leading cause of bacterial meningitis and pneumonia in children. The use of protein-polysaccharide conjugate vaccines in developed countries over the past two decades has markedly decreased the burden of disease and mortality from these organisms through direct protection of the immunized and through herd immunity. In the next decade, the widespread use of conjugate vaccines in the developing world should prevent millions of deaths. In this Science and Society article, we describe how vaccine-induced immunity wanes rapidly after vaccination in early childhood and argue that strategies that sustain protection in the population must be considered.

PMID:
19214194
DOI:
10.1038/nri2494
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center